Scope Fluidics

Scope Fluidics P/TBV

The Price to Tangible Book Value (P/TBV) of Scope Fluidics (SCP.WA) as of Oct 22, 2026 is 2.81. In the previous year, Price to Tangible Book Value (P/TBV) was 3.34 — a change of -15.89% (lower).

P/TBV

2.81

YoY

-15.89%

Last updated:

Price to Tangible Book Value (P/TBV) of Scope Fluidics is 2025 2.81 . Price to Tangible Book Value (P/TBV) of Scope Fluidics was 2024 3.34 . It decreases by -15.89% lower compared to the previous year.

The Scope Fluidics P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
44.04 PLN
Jan 1, 2019
35.81 PLN
Jan 1, 2020
42.56 PLN
Jan 1, 2021
47.51 PLN
Jan 1, 2022
1.40 PLN
Jan 1, 2023
6.12 PLN
Jan 1, 2024
3.34 PLN
Jan 1, 2025
2.81 PLN
The Scope Fluidics P/TBV history
YEARP/TBVYoY
2.81-15.89%
3.34-45.43%
6.12+338.49%
1.40-97.06%
47.51+11.65%
42.56+18.83%
35.81-18.68%
44.04+31.11%
33.59-88.86%
301.40+212.12%
96.57—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Scope Fluidics Stock analysis

What does Scope Fluidics do? Scope Fluidics SA generates revenue through the development and sale of disposable microfluidic systems for blood sample collection and reagent storage, targeting diagnostic and med-tech applications. The company's PCR ONE system detects bacterial and viral pathogens, while the BacterOMIC system provides data on bacterial susceptibility to antibiotics and resistance mechanisms. It offers laboratory access, workshops, and administrative services, including financing, to support its projects. Key clients include doctors, medical personnel, project managers, engineers, and academics who collaborate on its diagnostic solutions. The firm monetizes its R&D focus by providing specialized diagnostic tools and infrastructure services. Its products are designed for healthcare professionals and research institutions requiring advanced pathogen detection and antibiotic resistance analysis. By delivering both hardware systems like PCR ONE and BacterOMIC, and supporting services such as lab access and financing, Scope Fluidics SA serves the healthcare sector with tailored solutions for diagnostics and med-tech innovation. Scope Fluidics SA's revenue streams are derived from the sale of microfluidic systems, project support services, and access to its facilities. The company's target segments include medical professionals, researchers, and institutions engaged in diagnostic testing and antibiotic resistance studies. Its offerings combine hardware, software-free diagnostic tools, and collaborative infrastructure to address specific healthcare challenges in pathogen detection and treatment planning. Scope Fluidics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Scope Fluidics stock

Price to Tangible Book Value (P/TBV) of Scope Fluidics is 2.81 in 2025.

Price to Tangible Book Value (P/TBV) of Scope Fluidics changed from 3.34 to 2.81, representing a -15.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Scope Fluidics since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Scope Fluidics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Scope Fluidics

All Key Metrics — Scope Fluidics